Facts & Figures

Founded: 1996

Ownership: Privately Held

Investment Focus: Biopharmaceutical royalty interests

Assets: Royalty interests in forty four approved and marketed biopharmaceutical products and seven products in clinical trials and/or under review with the United States Food and Drug Administration (“FDA”) and/or the European Medicines Agency ("EMA”). 

Main Office:

110 East 59th Street
33rd Floor
New York, NY 10022

Contact Information:

This email address is being protected from spambots. You need JavaScript enabled to view it.
+1 (212) 883-0200

© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.